By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synta Pharmaceuticals 

45 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-274-8200 Fax: 781-274-8228



Company News
After Exploring Strategic Alternatives, Synta (SNTA) Agrees to Merge with Madrigal to Create Leading Cardio-Metabolic Diseases and NASH Company 4/14/2016 5:57:13 AM
Syntethic Biologics, Inc.' s Novel Irritable Bowel Syndrome With Constipation (IBS-C) Program Featured In Synta (SNTA) Poster 10/21/2015 11:37:36 AM
Stock Plunges as Synta (SNTA) Terminates Phase III Lung Cancer Study 10/21/2015 9:51:14 AM
Synta (SNTA) Announces Formation Of Expert Oncology Panel 10/8/2015 11:35:20 AM
Synta (SNTA) Names Alan C. Rigby, Ph.D. Chief Scientific Officer 9/9/2015 10:57:59 AM
Synta (SNTA) Announces Presentations At The 16th Annual World Conference On Lung Cancer 9/8/2015 11:19:31 AM
Synta (SNTA) To Participate In FBR Second Annual Healthcare Conference 9/3/2015 9:48:43 AM
Synta (SNTA) Reports Second Quarter 2015 Financial Results 8/6/2015 12:07:29 PM
Synta (SNTA) To Host Conference Call And Webcast Of Second Quarter 2015 Financial Results On August 6, 2015 7/31/2015 10:15:11 AM
Synta (SNTA) Announces Journal Publication Describing Complementary Activity Of Hsp90 Inhibition And Immune Checkpoint Blockade For Cancer Therapy 6/23/2015 11:31:02 AM